跳至主要内容
临床试验/EUCTR2015-000829-37-NL
EUCTR2015-000829-37-NL进行中(未招募)1 期

Fluid hydration to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis: the FLUYT-prevent trial. a multicenter randomized controlled superiority trial. - FLUYT-prevent trial

Radboud University Medical Center0 个研究点目标入组 826 人开始时间: 2015年4月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
826

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age between 17 and 86
  • written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 750
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 76

排除标准

  • 1) Allergy to NSAID’s or other contraindications
  • 2) Ongoing acute pancreatitis
  • 3) Ongoing hypotension, including those with sepsis
  • 4) Cardiac insufficiency (CI, >NYHA Class II heart failure)
  • 5) Renal insufficiency (RI, creatinin clearance <40ml/min)
  • 6) Active ulcer disease
  • 7) Severe liver dysfunction: Liver cirrhosis and ascites
  • 8) Respiratory insufficiency (pO2<60mmHg or 90% despite FiO2 of 30% or requiring mechanical ventilation).
  • 9) Pregnancy
  • 10) Hyponatremia (Na+ levels < 130mmol/l)
  • 11) Hypernatremia (Na+ levels > 150mmol/l)
  • 12) Oedema
  • 13) Low risk of PEP: chronic calcific pancreatitis or pancreatic head mass or routine biliary stent exchange; re-ERCP with a history of endoscopic sphincterotomy with a CBD intervention (PD intervention is allowed)
  • 14) Planned prophylactic pancreatic stent placement

研究者

相似试验